Latest Content

Dr. Elias Obeid says ongoing monitoring after treatment helps detect recurrence early and identify late effects, supporting survivorship for patients.

The U.S. FDA has issued an updated safety communication regarding two commonly used chemotherapy drugs, Xeloda and fluorouracil.

Dr. Suneel Kamath emphasized the growing importance of understanding biomarkers in patients with gastrointestinal cancers.

Relacorilant plus Abraxane showed benefit without biomarker testing, potentially expanding treatment access for patients with platinum-resistant ovarian cancer.

Oral KTX-1001 achieved 40% disease control in phase 1 trials, offering a new targeted therapy for aggressive t(4;14) translocation multiple myeloma.

Relacorilant plus Abraxane improved overall survival by 4.1 months without added toxicity and no biomarker testing in ROSELLA.

Dr. Joshua Sabari tells CURE that surgery, radiation and systemic therapy can affect the lungs, and he urges exercise and reporting new symptoms early.

Anxiety is not just an emotion but a presence with its own heartbeat, its own spirit, waiting in ambush for moments of vulnerability.

Dr. Meredith Pelster sat down for an interview with CURE to discuss new data surrounding new treatment outcomes for metastatic pancreatic cancer.

Dietitians share a fiber- and protein-rich pastina bean soup to help patients with colorectal cancer stay nourished and manage GI symptoms during treatment.

Fred Batchelor, a liver cancer survivor, shares lessons on advocacy and why World Cancer Day keeps patients, families and their communities engaged.

After a brain cancer diagnosis, Dr. Bobby Mukkamala says becoming a patient highlighted care barriers, emotions and the need for access and support.

In honor of World Cancer Day, CURE sat down with experts and advocates to discuss the importance of this initiative.